Celldex Therapeutics, Inc.
CLDX· Nasdaq
Released Aug 9, 2012, after the close
10-Q filed Aug 9, 2012, 40 days after period end · 0001104659-12-056527
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|
| Revenue | $2.01M | $1.95M | $2.95M |
| Net Income | — | -$10.24M | -$9.53M |
| EPS Diluted | -$0.23 | -$0.27 | -$0.30 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Celldex Therapeutics, Inc. · CIK 744218 · Engraved from SEC EDGAR